News

  1. Moderna And Novocol Pharma Announce Fill-Finish Agreement For Canadian-Made mRNA Vaccines 5/4/2023

    Moderna, Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines expected to be produced in Canada.

  2. SHL Medical And MoonLake Immunotherapeutics Collaborate To Develop Sonelokimab Autoinjector 5/3/2023

    SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake's Nanobody® sonelokimab based on SHL Medical's Molly® autoinjector technology.

  3. Hovione And H&T Presspart Extend Partnership To Advance High Efficiency Device Technology For Dry Powder Inhalation Formulation Delivery 5/3/2023

    Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.

  4. FDA Approval For High Potency Fill Line 4/19/2023

    Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high potency vial line to manufacture a commercial product.

  5. Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving The Important Milestone In Formulation Capability 4/19/2023

    Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the "Drug Manufacturing License" (C Certificate) by the Jiangsu Medical Products Administration, a branch of the Chinese National Medical Products Administration (NMPA).

  6. Berkshire Sterile Adds Non-Destructive Weight Checks To Their Low-Loss Fill Line 4/12/2023

    Berkshire Sterile Manufacturing (BSM), a fill finish CDMO located in Lee, MA, recently purchased a high precision load cell to perform non-destructive weight checks as part of their low loss fill process. The load cell is a Mettler Toledo WMF Series balance featuring unique capabilities to auto adjust for the environment and take highly accurate measurements in turbulent or highly unstable settings.

  7. Nutriband With Kindeva Drug Delivery Select Aversa Fentanyl Abuse Deterrent Formulation For Commercial Scale Manufacturing Process Development 4/4/2023

    Nutriband Inc. with Kindeva Drug Delivery (“Kindeva”) have selected the target AVERSA formulation to take forward into commercial scale manufacturing process development for the Company’s patented lead product, AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal system.

  8. Bridgewest Group Launches NovaCina, New Sterile Injectable CDMO 4/4/2023

    Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, launches new Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable drug products. This follows the recent announcement on the acquisition of the Perth sterile injectable manufacturing plant from Pfizer.

  9. Harm Reduction Therapeutics And Catalent Sign Commercial Supply Agreement For Naloxone Nasal Spray To Reverse Opioid Overdoses 3/23/2023

    Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone available to everyone, and Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the signing of a commercial supply agreement.

  10. Scaling Up Capacity, Eitan Medical Opens New Manufacturing Facility Bolstered by Semi-Automated Production Lines 3/22/2023

    Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today the opening of its new manufacturing facility at the company’s headquarters. On-site manufacturing will support Eitan Medical’s production scale of its Pharmaceutical Solutions division.